ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 164 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $672,000 | +55.9% | 73,717 | +155.2% | 0.00% | 0.0% |
Q4 2021 | $431,000 | -17.4% | 28,885 | +42.3% | 0.00% | 0.0% |
Q3 2021 | $522,000 | -45.5% | 20,294 | -44.7% | 0.00% | -50.0% |
Q2 2021 | $958,000 | +196.6% | 36,717 | +328.1% | 0.00% | +100.0% |
Q3 2020 | $323,000 | – | 8,576 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $45,386,000 | 9.32% |
TPG Group Holdings (SBS) Advisors, Inc. | 18,716,306 | $472,400,000 | 5.23% |
Wildcat Capital Management, LLC | 1,515,524 | $38,252,000 | 4.81% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 900,143 | $22,720,000 | 3.28% |
Coastal Bridge Advisors, LLC | 385,824 | $9,738,000 | 1.93% |
Casdin Capital, LLC | 945,000 | $23,852,000 | 0.71% |
DSAM Partners (London) Ltd | 208,798 | $5,270,000 | 0.62% |
BAINCO INTERNATIONAL INVESTORS | 152,839 | $3,858,000 | 0.44% |
Pier Capital, LLC | 152,071 | $3,838,000 | 0.41% |
Woodline Partners LP | 567,539 | $14,325,000 | 0.38% |